Clinical Trial Update: A Pharmacokinetics (PK) Study in Healthy Adults [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase pharmacokinetics study in healthy adults sponsored by Santen Pharmaceutical, investigating a therapy related to blepharoptosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharoptosis

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Blepharoptosis | EARLY_Phase 1 | Status: COMPLETED